Monograph

The ERS Monograph is the quarterly book series from the ERS.

Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.

Lung Transplantation

European Respiratory Society Monograph, Vol. 26. 2003

ISBN: 978-1-904097-94-5

DOI: 10.1183/1025448x.erm2603

Since the first attempt at human lung transplantation (LTx) by Hardy in the early 1960s, LTx has become an established treatment for a wide variety of end-stage cardiopulmonary diseases. Initially limited to patients with primary pulmonary hypertension or Eisenmenger's complex, this procedure was extended to patients with a variety of end-stage pulmonary disorders, such as end-stage fibrotic lung disease and end-stage obstructive lung disease as well as suppurative lung disorders, such as bronchiectasis or cystic fibrosis.

This issue of the European Respiratory Monograph offers the reader excellent state-of the-art information regarding experiences with LTx four decades after the first procedure. Increased physician awareness of LTx by discussion of the possibilities of organ donation, especially in the critical care setting, may also help to offer new perspectives for those patients suffering from otherwise fatal lung pathologies.

Preface E.F.M. Wouters Eur Respir Mon; 2003: 26: a
Introduction J. Boe, M. Estenne, W. Weder Eur Respir Mon; 2003: 26: b–c
Indications, patient selection and timing of referral for lung transplantation A.R. Glanville, M. Estenne Eur Respir Mon; 2003: 26: 1–15
The management of patients awaiting lung transplantation J.J. Egan Eur Respir Mon; 2003: 26: 16–30
Medical treatment of pulmonary arterial hypertension J-L. Vachiéry Eur Respir Mon; 2003: 26: 31–39
Lung volume reduction surgery W. Weder Eur Respir Mon; 2003: 26: 40–46
Pulmonary thromboendarterectomy E. Mayer, T. Kramm, S. Guth, K.F. Kreitner, B. Eberle, H. Oelert Eur Respir Mon; 2003: 26: 47–61
Organ shortage and the organisation of organ allocation B. Miranda, J. Canón , N. Cuende, M.T. Naya, G. Garrido, E. Fernández-Zincke Eur Respir Mon; 2003: 26: 62–77
Donor selection and management P.A. Corris Eur Respir Mon; 2003: 26: 78–85
Lung preservation D. Van Raemdonck, S. Steen Eur Respir Mon; 2003: 26: 86–97
Operative techniques H. Treede, H. Reichenspurner, W. Weder Eur Respir Mon; 2003: 26: 98–104
Immunosuppressive therapy after human lung transplantation C. Knoop, A. Haverich, S. Fischer Eur Respir Mon; 2003: 26: 105–129
Perioperative lung transplant management G. Snell, W. Klepetko Eur Respir Mon; 2003: 26: 130–142
Lung pathology S. Stewart Eur Respir Mon; 2003: 26: 143–157
Post-transplant bronchiolitis obliterans A. Boehler, M. Estenne Eur Respir Mon; 2003: 26: 158–178
Long-term management, functional outcome and results S.M. Studer, J.B. Orens, K. McNeil Eur Respir Mon; 2003: 26: 179–192
Infectious complications after lung transplantation W. van der Bij, R. Speich Eur Respir Mon; 2003: 26: 193–207
Noninfectious complications G. Mårtensson, J. Boe Eur Respir Mon; 2003: 26: 208–219
Effects of transplantation on lung and exercise physiology L.L. Schulman, M. Estenne Eur Respir Mon; 2003: 26: 220–242
Paediatric lung transplantation G.B. Mallory Jr Eur Respir Mon; 2003: 26: 243–256
Living-donor lobar transplantation M.E. Bowdish, M.L. Barr, V.A. Starnes Eur Respir Mon; 2003: 26: 257–268
Economic evaluation and quality of life E.M. TenVergert, H. Groen, K.M. Vermeulen Eur Respir Mon; 2003: 26: 269–284
Future prospects R.D. Davis Jr, K. Gandy Eur Respir Mon; 2003: 26: 285–300